TA142: Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin
This is a discussion on TA142: Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin. It links ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA142: Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin
The summary for the published technology appraisal on Anaemia (cancer-treatment induced) - erythropoietin (alpha and beta) and darbepoetin. It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Erythropoietin Appears Safe for Heart Failure Patients | industry_news | Other Clinical Pharmacy News | 0 | 08-18-2009 01:54 PM |
| Increasing BMI May Impact Choice of Prostate Cancer Treatment | industry_news | Other Clinical Pharmacy News | 0 | 09-25-2008 02:15 PM |
| Amgen Stops Rebates for Darbepoetin, Alters Discount Policy | industry_news | Other Clinical Pharmacy News | 0 | 09-05-2008 12:23 PM |
| High-Dose Erythropoietin Safe for Very Preterm Infants | industry_news | Other Clinical Pharmacy News | 0 | 08-05-2008 10:20 AM |
| Endogenous Erythropoietin Tied to Outcome in Anemic Heart Patients | industry_news | Other Clinical Pharmacy News | 0 | 07-18-2008 02:32 PM |
© 2008 DrugManagementForum™ powered by |
 |